Centaurus Financial’s MediciNova MNOV Stock Holding History

Centaurus Financial’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,000	Closed	-$40K	–	1449
2018 Q2	$40K	Buy	+5,000	New	+$51.7K	0.01%	1030

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Centaurus Financial's MNOV Position: Q3 2018 in Review

Centaurus Financial sold out of MediciNova (MNOV) in Q3 2018, closing a stake of 5,000 shares — an estimated $40K sold.

Centaurus Financial first reported a position in MNOV in Q2 2018 and held it in 1 quarter. The position peaked at $40K in Q2 2018. 46 funds tracked by Wall St. Rank hold MNOV as of Q3 2018.

Centaurus Financial reported no remaining MediciNova position as of Q3 2018 after selling out during the quarter.
Centaurus Financial sold 5,000 MediciNova shares in Q3 2018, an estimated $40K.
Centaurus Financial first reported a position in MediciNova in Q2 2018 and held it in 1 quarter.
Centaurus Financial's MediciNova position peaked at $40K in Q2 2018.
46 funds tracked by Wall St. Rank held MediciNova as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.